000 02304cam a2200349 a 4500
003 EG-GiCUC
005 20250223031117.0
008 141207s2014 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.05.Ph.D.2014.Ah.E
100 0 _aAhmed Gamil Mohamed Ali Karmota
245 1 0 _aEndovascular management of supraaortic trunks diseases /
_cAhmed Gamil M. Ali Karmota ; Supervised Hussein Kamal Eldin Hussein , Hussein Mahmoud Khairy , Ahmed Abdelhamid Taha
246 1 5 _aعلاج أمراض الشرايين العظمى لشريان جذع الأورطى باستخدام القسطرة العلاجية
260 _aCairo :
_bAhmed Gamil Mohamed Ali Karmota ,
_c2014
300 _a150 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Cardiothoracic Surgery
520 _aTo review the role of endovascular therapy in the management of SATs diseases. Prospective study during the period from March 2011 to February 2013. from 13 consecutive symptomatic patients with occlusive disease in 6 patient (46.1%) and aneurismal diseases in 8 patient (11 men and 2 women, median age 51.5ys for atherosclerotic pathological lesions and 34.5ys for traumatic cases. All cases were symptomatic. All patient with occlusive atherosclerotic lesions have 1ry stenting with predilatation. Endograft were used in all patients with arterial injury and pseudoaneurysm. 1ry technical success was achieved in all occlusive lesion 6 / 6 (100%) 3 of which are stenotic while 3 lesions are total occlusion 1ry technical success was occur in 9 / 10 (90%) lesions in patient with traumatic and aneurismal disease, 1/9 (11%) lesion with atherosclerotic aneurysm was complicated with distal embolization and failure to exclude the aneurysm
530 _aIssued also as CD
653 4 _aEndograft
653 4 _aEndovascular
653 4 _aSATs diseases
700 0 _aAhmed Abdelhamid Taha ,
_eSupervisor
700 0 _aHussein Kamal Eldin Hussein ,
_eSupervisor
700 0 _aHussein Mahmoud Khairy ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c48607
_d48607